Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,719,970
- Total 13F shares
- 3,452,402
- Share change
- +446,396
- Total reported value
- $4,282,000
- Price per share
- $1.24
- Number of holders
- 19
- Value change
- +$542,449
- Number of buys
- 8
- Number of sells
- 10
Report period
Q3 2020
Institutions
19
Top holders
10
CLRB full security history
Newer quarter: Q4 2020
Previous quarter: Q2 2020
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Boxer Capital, LLC |
13F
|
Company |
11%
|
920,000
|
$1,178,000 | — | 30 Jun 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
9.1%
|
790,602
|
$1,012,000 | — | 30 Jun 2020 | |
| Worth Venture Partners, LLC |
13F
|
Company |
4.6%
|
399,126
|
$511,000 | — | 30 Jun 2020 | |
| Sio Capital Management, LLC |
13F
|
Company |
2.2%
|
189,457
|
$243,000 | — | 30 Jun 2020 | |
| CVI Holdings, LLC |
13F
|
Company |
1.6%
|
139,979
|
$179,000 | — | 30 Jun 2020 | |
| Quilter Plc |
13F
|
Company |
1.6%
|
137,106
|
$175,000 | — | 30 Jun 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
1.5%
|
128,321
|
$164,000 | — | 30 Jun 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1%
|
87,500
|
$112,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.63%
|
55,300
|
$71,000 | — | 30 Jun 2020 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.46%
|
40,270
|
$52,000 | — | 30 Jun 2020 | |
| Game Plan Financial Advisors, LLC |
13F
|
Company |
0.45%
|
39,624
|
$51,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.19%
|
16,755
|
$21,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
14,034
|
$18,000 | — | 30 Jun 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.13%
|
11,001
|
$14,000 | — | 30 Jun 2020 | |
| Independence Advisors, LLC |
13F
|
Company |
0.11%
|
10,000
|
$13,000 | — | 30 Jun 2020 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.11%
|
10,000
|
$13,000 | — | 30 Jun 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.09%
|
7,708
|
$10,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
3,000
|
$4,000 | — | 30 Jun 2020 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
2,857
|
$4,000 | — | 30 Jun 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
2,221
|
$3,000 | — | 30 Jun 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,145
|
$1,000 | — | 30 Jun 2020 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.01%
|
500
|
$1,000 | — | 30 Jun 2020 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q3 2020
As of 30 Sep 2020,
Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,452,402 shares.
The largest 10 holders included
Sio Capital Management, LLC, BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, FNY Investment Advisers, LLC, Worth Venture Partners, LLC, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, Quilter Plc, WEDBUSH SECURITIES INC, and NORTHERN TRUST CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
21
Q3 2020 holders
19
Holder diff
-2
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.